
HQ: Culver City, California, United States
About ImmunityBio Company
ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.
ImmunityBio Specialization
Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
ImmunityBio General Information
HQ: Culver City, California, United States
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Founded Date: 2014
Company Type: For Profit
Stock Symbol: NASDAQ:IBRX
Operating Status: Active
Last Funding Type: Post-IPO Debt
Phone Number: (310) 883-1300
Sub-Organization of: NantWorks
Last Investment Activity: Mar 19, 2024
Investments Activity: Mar 19, 2024 Feb 21, 2024 Jan 2, 2024
ImmunityBio Email Format
{first_name}@immunitybio.com — 50.0% (example: sarah@domain.com)
{first_name}.{last_name}@immunitybio.com — 50.0% (example: sarah.smith@domain.com)
ImmunityBio General ImmunityBio Emails
General Inquiries
info@immunitybio.com
General Inquiries
hello@immunitybio.com
Admin Team
admin@immunitybio.com
Investor Relations
investor@immunitybio.com
Management Department
manager@immunitybio.com
Contact details of 2 ImmunityBio executives
Patrick Soon-Shiong
-
Work email
p*****k@immunitybio.com
Similar Companies like ImmunityBio

HQ: Rahway, New Jersey, United States
Merck is a biopharmaceutical company that offers medicines a...
HQ: Rahway, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active

HQ: New York, New York, United States
Pfizer is a biopharmaceutical company that provides affordab...
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital

HQ: New York, New York, United States
Pfizer is a biopharmaceutical company that provides affordab...
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 9, 2024
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.